Cytoreductive prostatectomy improves survival outcomes in patients with oligometastases: a systematic meta-analysis

Y Mao, M Hu, G Yang, E Gao, W Xu - World Journal of Surgical Oncology, 2022 - Springer
Background Whether cytoreductive prostatectomy (CRP) should be performed in patients
with oligometastatic prostate cancer (OPC) remains controversial. The goal of this systematic …

[HTML][HTML] Canadian Urological Association best practice report: Prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET …

B Shaygan, K Zukotynski, F Bénard… - Canadian Urological …, 2021 - ncbi.nlm.nih.gov
Prostate-specific membrane antigen (PSMA)-targeted positron emission tomography (PET)
is increasingly being used worldwide as part of the clinical workup for men with prostate …

[HTML][HTML] Current treatment patterns within 1 year after prostate cancer diagnosis in Korean patients over 75 years old: a retrospective multicenter study

DJ Park, HW Kang, SY Kwon, YJ Seo, KS Lee… - Prostate …, 2023 - Elsevier
Background We aimed to evaluate the current status of first-line treatment options for
prostate cancer in patients aged≥ 75 years in Korea. Materials and methods The study …

[HTML][HTML] A comparison of the survival outcomes of robotic-assisted radical prostatectomy and radiation therapy in patients over 75 years old with non-metastatic …

YH Ko, SW Park, US Ha, JY Joung… - … and clinical urology, 2021 - ncbi.nlm.nih.gov
Purpose To compare overall survivals (OSs) and cancer-specific survivals (CSSs) after
robotic-assisted radical prostatectomy (RARP) and radiation therapy (RT), the latter of which …

The comparison of the survival outcome between robotic-assisted radical prostatectomy and radiation therapy for localized prostate cancer in men over 70 years …

YH Ko - Journal of Robotic Surgery, 2021 - Springer
This study aimed to investigate the survival after robotic-assisted radical prostatectomy
(RARP) in comparison with radiation therapy (RT) in elderly patients (≥ 70 years) with non …

Clinical outcomes and prognosis of metastatic prostate cancer patients≤ 60-year-old

H Kim, S Lee, SS Byun, SK Hong - World Journal of Urology, 2021 - Springer
Purpose Metastatic prostate cancer (mPCa) rarely occurs under the age of 60, and we aim to
evaluate the clinical outcomes and prognosis of mPCa patients≤ 60-year-old. Methods Two …

Circulating tumor cells in patients undergoing androgen deprivation therapy with versus without cryosurgery for metastatic prostate cancer: a retrospective analysis

M Sheng, S Guo, C Liu - World Journal of Surgical Oncology, 2021 - Springer
Background The study aimed to assess the value of circulating tumor cells (CTCs) as a
prognostic and treatment response marker in patients undergoing androgen deprivation …

Clinical Significance of Radical Prostatectomy in Clinical Lymph Node Metastasis in Prostate Cancer

D Kim, B Lim, J Suh, D You, IG Jeong, JH Hong… - Annals of Surgical …, 2023 - Springer
Background This study aimed to investigate the role of radical prostatectomy (RP) among
clinical nodal metastasis prostate cancer and whether histological confirmation of lymph …

[图书][B] Le cancer de la prostate

O Cussenot, P Teillac - 2000 - books.google.com
Page 1 5BM iDN PATHOLOGIE SCIENCE ORMATION Le cancer de la prostate Olivier
Cussenot Pierre Teillac JJohn ORN EUROTEXT Libbey Page 2 Page 3 Le cancer de la …

[HTML][HTML] Первый опыт выполнения циторедуктивной простатэктомии у пациентов с олигометастатическим раком предстательной железы после …

ВО Магер, АС Орлов, ТР Гильмутдинов… - …, 2021 - cyberleninka.ru
Введение. В настоящее время не существует единого мнения о месте
циторедуктивной простатэктомии в комплексном лечении пациентов с …